Home > Research > Publications & Outputs > Identification of challenges to the availabilit...

Electronic data

  • LingeDahl ATOME 6Country-workshop draft revision 14 07 2015_final

    Rights statement: Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/10.1089/jpm.2015.0051

    Accepted author manuscript, 204 KB, PDF-document

    Available under license: CC BY: Creative Commons Attribution 4.0 International License

Links

Text available via DOI:

View graph of relations

Identification of challenges to the availability and accessibility of opioids in twelve European countries: conclusions from two ATOME six-country workshops

Research output: Contribution to journalJournal article

Published
  • Lisa Linge-Dahl
  • Marjolein J. M. Vranken
  • Saskia Jünger
  • Kate North
  • Willem Scholten
  • Sheila Alison Payne
  • Lukas Radbruch
Close
<mark>Journal publication date</mark>12/2015
<mark>Journal</mark>Journal of Palliative Medicine
Issue number12
Volume18
Number of pages7
Pages (from-to)1033-1039
StatePublished
Early online date20/10/15
Original languageEnglish

Abstract

Background: Access to many controlled medicines is inadequate in a number of European countries. This leads to deficits in the treatment of moderate to severe pain as well as in opioid agonist therapy.

Objective: The study objective was to elaborate the reasons for this inadequacy. The work plan of the Access to Opioid Medication in Europe (ATOME) project included two six-country workshops. These workshops comprised a national situational analysis, drafting tailor-made recommendations for improvement and developing action plans for their implementation.

Methods: In total, 84 representatives of the national Ministries of Health, national controlled substances authorities, experts representing regulatory and law enforcement authorities, leading health care professionals, and patient representatives from 13 European countries participated in either one of the workshops. The delegates used breakout sessions to identify key common challenges. Content analysis was used for the evaluation of protocols and field notes.

Results: A number of challenges to opioid accessibility in the countries was identified in the domains of knowledge and educational, regulatory, legislative, as well as public awareness and training barriers that limit opioid prescription. In addition, short validity of prescriptions and bureaucratic practices resulting in overregulation impeded availablity of some essential medicines. Stigmatization and criminalisation of people who use drugs remained the major impediment to increasing opioid agonist program coverage.

Conclusions: The challenges identified during outcomes of the workshops were used as the basis for subsequent dissemination and implementation activities in the ATOME project, and in some countries the workshop proceedings already served as a stepping-stone for the first changes in regulations and legislation.

Bibliographic note

Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/10.1089/jpm.2015.0051